Skip to main content
FinSpry Logo
FinSpry
TLX logo
TLX
(NASDAQ)
Telix Pharmaceuticals Limited
$10.86-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Telix Pharmaceuticals (TLX) Stock Price & Financial Analysis

Telix Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.78 - $10.95
52-Week High$16.98
52-Week Low$6.28
Open$10.83
Volume106.92K
Average Volume (3M)181.69K
Market Cap3.67B
Shares Outstanding337.88M
Price to Sales (P/S)4.57
Price to Book (P/B)8.83
EV/EBITDA76.83
Revenue (TTM)803.79M
Net Income (TTM)-7.13M
Free Cash Flow (TTM)-61.07M
EPS (TTM)$-0.02
Profit Margin-0.89%
Operating Margin3.70%
Return on Equity (ROE)-1.72%
Debt to Equity0.98
50-Day MA$10.17
200-Day MA$9.17
52-Week Change-32.08%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateApr 18, 2006

Frequently Asked Questions About Telix Pharmaceuticals

What is the current stock price for TLX?

As of the latest trading session, TLX stock trades at $10.86. The 52-week range is $6.28–$16.98, with a day range of $10.78–$10.95.

What is the P/E ratio for TLX?

The P/E ratio (Price-to-Earnings) for TLX is shown in the Key Statistics section. This valuation metric helps compare Telix Pharmaceuticals Limited to industry peers.

Does TLX pay dividends?

Telix Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TLX?

Based on 2 analysts, the consensus for TLX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TLX?

Telix Pharmaceuticals's market capitalization is $3.67B, classifying it as a mid-cap company. Telix Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.